Caloric Restriction
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The CALERIE randomized controlled trial (about 220 participants, 2 years) is graded moderate human RCT evidence for biological aging biomarkers and cardiometabolic risk factors, but no human RCT has or can measure a mortality/lifespan endpoint, so it falls short of grade 4.
Reference only. Not medical advice.
Caloric restriction means sustained reduction of calorie intake, typically 15 to 40 percent below usual intake, while maintaining adequate protein, vitamins, and minerals to avoid malnutrition. In laboratory rodents and many other species, CR is one of the most reproducible ways to extend both median and maximum lifespan, an effect documented across nearly a century of research. Proposed mechanisms include reduced signaling through insulin/IGF-1 and mTOR pathways, increased autophagy, improved mitochondrial efficiency, reduced chronic inflammation, and activation of stress-resistance pathways associated with sirtuins and AMPK. Whether these mechanisms translate into extended human lifespan is unresolved, because no trial can practically follow humans for the decades needed to measure a lifespan endpoint. The strongest human evidence comes from CALERIE, a multi-site randomized controlled trial that assigned about 220 healthy, non-obese adults to two years of roughly 12 to 15 percent sustained calorie restriction or a normal diet. CALERIE found improvements in cardiometabolic risk factors, reduced inflammatory markers, and a small but statistically detectable slowing (about 2 to 3 percent) of the pace of biological aging measured by the DunedinPACE DNA-methylation clock, an effect that in observational cohorts correlates with lower later-life mortality risk, though CALERIE itself did not and could not measure mortality directly. Observational data from long-term CR practitioners (such as members of the CRON society) and comparative population studies (for example, Okinawan cohorts with historically lower caloric intake) are supportive but confounded by self-selection and other lifestyle factors. Currently, sustained calorie restriction below nutritional needs is a research and self-experimentation practice, not a clinical treatment, and it is not recommended for people who are underweight, pregnant, growing, elderly with sarcopenia risk, or who have a history of eating disorders. Caveats include loss of lean muscle mass and bone density with aggressive restriction, potential effects on fertility and immune function, and the difficulty of long-term adherence outside a research setting. Milder, more sustainable approaches such as modest calorie reduction combined with adequate protein and resistance exercise are generally viewed as more practical for most people than severe restriction.
Caloric restriction means sustained reduction of calorie intake, typically 15 to 40 percent below usual intake, while maintaining adequate protein, vitamins, and minerals to avoid malnutrition.
Safety in detail
Sustained restriction below nutritional needs can cause loss of lean mass, bone density loss, menstrual irregularities, and is not appropriate for children, pregnant people, underweight individuals, or those with a history of disordered eating; medical supervision is advised for restriction beyond mild, modest reduction.
What people get wrong
Nothing recorded here yet. There is almost certainly something people get wrong about this one, and the blank space means we have not written it down, not that the record is clean.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
The field traces to Clive McCay's 1935 Cornell experiments, which showed that rats fed a nutrient-adequate but roughly 20 to 40 percent lower calorie diet from a young age lived substantially longer than freely fed controls, a finding widely cited as the origin of dietary restriction research. For decades the effect was studied almost entirely in rodents and other short-lived species, with primate studies (Wisconsin and NIA colonies) beginning in the 1980s to 1990s giving mixed results depending on diet composition and control-group feeding levels. The first large randomized trial of moderate CR in healthy, non-obese humans, CALERIE, launched in the 2000s and reported results in the 2010s and 2020s, shifting the question from whether CR extends rodent lifespan (well established) to whether it measurably slows human biological aging (an open, actively studied question).
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Caloric Restriction. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
- Where we land. We have not taken a position on this yet.
- What people take it for. We have not catalogued the claims made for it.